• Je něco špatně v tomto záznamu ?

VirPorters: Insights into the action of cationic and histidine-rich cell-penetrating peptides

J. Váňová, B. Číhařová, A. Hejtmánková, CP. Epperla, P. Škvára, J. Forstová, M. Hubálek Kalbáčová, H. Španielová

. 2022 ; 611 (-) : 121308. [pub] 20211118

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22002970

The utilization of nanoparticles for the intracellular delivery of theranostic agents faces one substantial limitation. Sequestration in intracellular vesicles prevents them from reaching the desired location in the cytoplasm or nucleus to deliver their cargo. We investigated whether three different cell-penetrating peptides (CPPs), namely, octa-arginine R8, polyhistidine KH27K and histidine-rich LAH4, could promote cytosolic and/or nuclear transfer of unique model nanoparticles-pseudovirions derived from murine polyomavirus. Two types of CPP-modified pseudovirions that carry the luciferase reporter gene were created: VirPorters-IN with CPPs genetically attached to the capsid interior and VirPorters-EX with CPPs noncovalently associated with the capsid exterior. We tested their transduction ability by luciferase assay and monitored their presence in subcellular fractions. Our results confirmed the overall effect of CPPs on the intracellular destination of the particles and suggested that KH27K has the potential to improve the cytosolic release of pseudovirions. None of the VirPorters caused endomembrane damage detectable by the Galectin-3 assay. Remarkably, a noncovalent modification was required to promote high transduction of the reporter gene and cytosolic delivery of pseudovirions mediated by LAH4. Together, CPPs in different arrangements have demonstrated their potential to improve pseudovirion invasion into cells, and these findings could be useful for the development of other nanoparticle-based delivery systems.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22002970
003      
CZ-PrNML
005      
20220127150749.0
007      
ta
008      
220113s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2021.121308 $2 doi
035    __
$a (PubMed)34800617
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Váňová, Jana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44 Prague 2, Czech Republic
245    10
$a VirPorters: Insights into the action of cationic and histidine-rich cell-penetrating peptides / $c J. Váňová, B. Číhařová, A. Hejtmánková, CP. Epperla, P. Škvára, J. Forstová, M. Hubálek Kalbáčová, H. Španielová
520    9_
$a The utilization of nanoparticles for the intracellular delivery of theranostic agents faces one substantial limitation. Sequestration in intracellular vesicles prevents them from reaching the desired location in the cytoplasm or nucleus to deliver their cargo. We investigated whether three different cell-penetrating peptides (CPPs), namely, octa-arginine R8, polyhistidine KH27K and histidine-rich LAH4, could promote cytosolic and/or nuclear transfer of unique model nanoparticles-pseudovirions derived from murine polyomavirus. Two types of CPP-modified pseudovirions that carry the luciferase reporter gene were created: VirPorters-IN with CPPs genetically attached to the capsid interior and VirPorters-EX with CPPs noncovalently associated with the capsid exterior. We tested their transduction ability by luciferase assay and monitored their presence in subcellular fractions. Our results confirmed the overall effect of CPPs on the intracellular destination of the particles and suggested that KH27K has the potential to improve the cytosolic release of pseudovirions. None of the VirPorters caused endomembrane damage detectable by the Galectin-3 assay. Remarkably, a noncovalent modification was required to promote high transduction of the reporter gene and cytosolic delivery of pseudovirions mediated by LAH4. Together, CPPs in different arrangements have demonstrated their potential to improve pseudovirion invasion into cells, and these findings could be useful for the development of other nanoparticle-based delivery systems.
650    _2
$a zvířata $7 D000818
650    _2
$a biotest $7 D001681
650    _2
$a kationty $7 D002412
650    12
$a penetrační peptidy $7 D057846
650    _2
$a cytosol $7 D003600
650    _2
$a histidin $7 D006639
650    _2
$a myši $7 D051379
655    _2
$a časopisecké články $7 D016428
700    1_
$a Číhařová, Barbora $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44 Prague 2, Czech Republic
700    1_
$a Hejtmánková, Alžběta $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44 Prague 2, Czech Republic; Institute of Pathological Physiology, 1(st) Faculty of Medicine, Charles University, U Nemocnice 5, 128 53 Prague 2, Czech Republic. Electronic address: sekavova@natur.cuni.cz
700    1_
$a Epperla, Chandra Prakash $u Institute of Organic Chemistry and Biochemistry of the CAS, Flemingovo náměstí 542/2, 166 10 Prague 6, Czech Republic
700    1_
$a Škvára, Petr $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44 Prague 2, Czech Republic
700    1_
$a Forstová, Jitka $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44 Prague 2, Czech Republic
700    1_
$a Hubálek Kalbáčová, Marie $u Institute of Pathological Physiology, 1(st) Faculty of Medicine, Charles University, U Nemocnice 5, 128 53 Prague 2, Czech Republic. Electronic address: marie.kalbacova@lf1.cuni.cz
700    1_
$a Španielová, Hana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44 Prague 2, Czech Republic; Institute of Organic Chemistry and Biochemistry of the CAS, Flemingovo náměstí 542/2, 166 10 Prague 6, Czech Republic. Electronic address: hana.spanielova@natur.cuni.cz
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 611, č. - (2022), s. 121308
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34800617 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150745 $b ABA008
999    __
$a ok $b bmc $g 1750684 $s 1154119
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 611 $c - $d 121308 $e 20211118 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...